Onconetix receives second Nasdaq delisting notice for late 10-Q; hearing set May 27

Onconetix, Inc.

Received Nasdaq deficiency notice May 20 for failure to timely file Q1 2025 10-Q, adding to existing non-compliance for late 10-K.
Company also faces delisting due to bid price below $0.10 for 10 consecutive days; hearing before Nasdaq Panel scheduled May 27.
Issued $294,117.65 promissory note to Keystone Capital Partners with OID of $44,117.65; due Feb 2026 or upon equity line proceeds.
No assurance Panel will grant stay; stock delisting would follow if unfavorable decision.
Company intends to file 10-K and 10-Q as promptly as possible to regain compliance.

item 1.01item 2.03item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.